A detailed history of Black Rock Inc. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,830,880 shares of ORIC stock, worth $46.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,830,880
Previous 3,178,185 52.0%
Holding current value
$46.8 Million
Previous $43.7 Million 21.84%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.63 - $12.93 $11 Million - $21.4 Million
1,652,695 Added 52.0%
4,830,880 $34.2 Million
Q1 2024

May 10, 2024

BUY
$8.04 - $16.03 $663,597 - $1.32 Million
82,537 Added 2.67%
3,178,185 $43.7 Million
Q4 2023

Feb 13, 2024

SELL
$5.41 - $9.43 $3.45 Million - $6.01 Million
-636,958 Reduced 17.06%
3,095,648 $28.5 Million
Q3 2023

Nov 13, 2023

BUY
$6.05 - $9.28 $7 Million - $10.7 Million
1,157,325 Added 44.94%
3,732,606 $22.6 Million
Q2 2023

Aug 11, 2023

BUY
$4.95 - $8.4 $9.33 Million - $15.8 Million
1,884,767 Added 272.95%
2,575,281 $20 Million
Q1 2023

May 12, 2023

SELL
$4.26 - $6.75 $459,543 - $728,149
-107,874 Reduced 13.51%
690,514 $3.94 Million
Q4 2022

Feb 13, 2023

SELL
$2.41 - $5.89 $579,735 - $1.42 Million
-240,554 Reduced 23.15%
798,388 $4.7 Million
Q3 2022

Nov 14, 2022

BUY
$3.15 - $5.24 $754,743 - $1.26 Million
239,601 Added 29.97%
1,038,942 $3.32 Million
Q2 2022

Aug 12, 2022

SELL
$2.7 - $7.07 $4.25 Million - $11.1 Million
-1,574,559 Reduced 66.33%
799,341 $3.58 Million
Q1 2022

May 12, 2022

SELL
$4.54 - $16.1 $188,169 - $667,296
-41,447 Reduced 1.72%
2,373,900 $12.7 Million
Q4 2021

Feb 10, 2022

BUY
$12.01 - $20.3 $57,708 - $97,541
4,805 Added 0.2%
2,415,347 $35.5 Million
Q3 2021

Nov 09, 2021

BUY
$15.9 - $25.22 $2.23 Million - $3.54 Million
140,232 Added 6.18%
2,410,542 $50.4 Million
Q2 2021

Aug 11, 2021

BUY
$17.37 - $25.34 $39.4 Million - $57.5 Million
2,270,310 New
2,270,310 $40.2 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $383M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.